1. Home
  2. XELB vs CYTH Comparison

XELB vs CYTH Comparison

Compare XELB & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • CYTH
  • Stock Information
  • Founded
  • XELB 2011
  • CYTH 1990
  • Country
  • XELB United States
  • CYTH United States
  • Employees
  • XELB N/A
  • CYTH N/A
  • Industry
  • XELB Multi-Sector Companies
  • CYTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • CYTH Health Care
  • Exchange
  • XELB Nasdaq
  • CYTH Nasdaq
  • Market Cap
  • XELB 19.0M
  • CYTH 20.4M
  • IPO Year
  • XELB N/A
  • CYTH N/A
  • Fundamental
  • Price
  • XELB $0.51
  • CYTH $0.66
  • Analyst Decision
  • XELB
  • CYTH Buy
  • Analyst Count
  • XELB 0
  • CYTH 3
  • Target Price
  • XELB N/A
  • CYTH $0.95
  • AVG Volume (30 Days)
  • XELB 359.0K
  • CYTH 59.2K
  • Earning Date
  • XELB 12-20-2024
  • CYTH 11-14-2024
  • Dividend Yield
  • XELB N/A
  • CYTH N/A
  • EPS Growth
  • XELB N/A
  • CYTH N/A
  • EPS
  • XELB N/A
  • CYTH N/A
  • Revenue
  • XELB $9,337,000.00
  • CYTH $870,725.00
  • Revenue This Year
  • XELB N/A
  • CYTH N/A
  • Revenue Next Year
  • XELB $82.99
  • CYTH $24.49
  • P/E Ratio
  • XELB N/A
  • CYTH N/A
  • Revenue Growth
  • XELB N/A
  • CYTH N/A
  • 52 Week Low
  • XELB $0.33
  • CYTH $0.55
  • 52 Week High
  • XELB $1.70
  • CYTH $2.12
  • Technical
  • Relative Strength Index (RSI)
  • XELB 43.26
  • CYTH 55.40
  • Support Level
  • XELB $0.33
  • CYTH $0.55
  • Resistance Level
  • XELB $0.53
  • CYTH $0.64
  • Average True Range (ATR)
  • XELB 0.09
  • CYTH 0.05
  • MACD
  • XELB 0.01
  • CYTH 0.01
  • Stochastic Oscillator
  • XELB 43.27
  • CYTH 88.64

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

Share on Social Networks: